SCA Pharmaceuticals: Injectable Medications Recalled for Potential Lack of Sterility

What You Should Do

1. Check any injectable medications provided by your hospital or healthcare facility against the extensive list of affected products, including Rocuronium, Succinylcholine, Ephedrine, Fentanyl, Hydromorphone, Phenylephrine, Ketamine, Atropine, Lidocaine, Esmolol, Glycopyrrolate, Labetalol, Morphine, Neostigmine, and Sodium Citrate.
2. Identify affected products by checking for specific lot numbers and 'Beyond Use Dates' (BUD) on the syringe label, such as Fentanyl 100 mcg/2mL Lot #1220023109 (BUD 1/25/2021) or Morphine Sulfate 3 mg/3 mL Lot #1220023452 (BUD 2/7/2021).
3. If you believe you have an affected syringe or have received treatment using one of these medications, contact your healthcare provider or pharmacist immediately for guidance.
4. Health care facilities should immediately quarantine any remaining stock of the listed lots and contact SCA Pharmaceuticals at 755 Rainbow Rd Ste B, Windsor, CT 06095 to arrange for returns.
5. Return any unused recalled product to your pharmacy or the place of purchase for a refund and contact SCA Pharmaceuticals for further instructions.
6. For additional questions or to report a complaint, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Affected Products